Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-03

Clinical Trial Update: Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating transcutaneous tibial nerve stimulation for overactive bladder (including patients with multiple sclerosis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcutaneous tibial nerve stimulation

Snippet

Sponsor: University College, London | Conditions: Overactive Bladder, Multiple Sclerosis | Phase 2 | Status: COMPLETED